Alle Studien
RekrutierungInterventionell

App-based financial incentives to encourage naloxone carriage

Naloxone is an emergency medicine that rapidly reverses the effects of an opioid overdose. Many people who use opioids are given a take-home naloxone kit so they, or someone nearby, can act quickly in a crisis. However, research shows that people rarely carry their kits when they are out and about, meaning naloxone may not be close by when an emergency happens. This study, led by King's College London, tests whether a smartphone app can help build the habit of carrying naloxone. Forty participants will download the app and receive naloxone training. Half of the participants will receive small cash rewards (up to £2) when they take a quick photo to show they have their kit with them outside. Researchers will check in after 6 and 10 weeks to see if the app is practical, acceptable, and easy to use.

Auf einen Blick

Status
Rekrutierung
Sponsor
King's College London
Einschreibeziel
40
Starten
03 Aug 2026
Geschätzte Fertigstellung
30. Nov 2026

Worum geht es in dieser Studie?

Naloxone is a life-saving medication used to quickly reverse an opioid overdose. Across the UK, people who use opioids can get take-home naloxone kits. The idea is simple: if someone has an overdose, friends, family, or passers-by have the medicine ready to keep them alive until an ambulance arrives.

Even though these kits are widely handed out, studies show that people rarely carry them when they leave home. If an overdose takes place away from home, the kit is left behind and cannot help. Researchers want to find positive, practical ways to help people remember to bring their kit with them every day.

This study is testing an approach called 'contingency management', which uses small rewards to encourage healthy habits. Researchers have built a smartphone app that sends occasional reminders when a person leaves home. If the user confirms they have their naloxone kit, they receive a small financial reward. By testing this app with a small group first, the team hopes to see whether it works well before trying it in a larger project across the NHS.

Wichtige Erkenntnisse

  • Tests a smartphone app designed to help people remember to carry their life-saving naloxone kits.
  • Open to adults aged 18+ who use opioids and have a take-home naloxone kit.
  • Uses small cash rewards (up to £2) when users verify they have their kit with them.
  • Involves training, using the app, and two short follow-up interviews over 10 weeks.
  • Taking part is voluntary and does not alter your regular healthcare or support.

Wer könnte berechtigt sein?

This study is open to adults aged 18 and over who currently use opioids and have already received a take-home naloxone kit.

To take part, you must own an active smartphone with mobile data and be able to bring it with you when you enrol. You will also need to bring your naloxone kit to your first meeting so staff can verify it.

People who do not have regular access to a working smartphone with mobile internet cannot take part, as the study relies entirely on using the mobile app.

Könnte diese Studie für Sie geeignet sein?

Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.

  1. I am at least 18 years old.
  2. I currently use opioids.
  3. I have a take-home naloxone kit that I can bring to show the team.
  4. I own a smartphone with active mobile data.
  5. I can attend follow-up check-ins remotely or at a clinic in London or Derby.
Beantworten Sie jede Frage, um Ihr Ergebnis zu sehen.

Was beinhaltet die Teilnahme?

Taking part lasts for about 10 weeks. At the start, you will receive training on how to use naloxone and help installing the study app on your smartphone. Participants are randomly put into one of two groups: both groups get the app and training, but one group will receive prompts when leaving home asking them to verify their naloxone kit using their camera for a £2 reward (or £1 if they are not carrying it and explain why).

You will not need to take any new medications. You will complete follow-up check-ins at 6 weeks and 10 weeks to discuss your experience, your drug use, and how the app worked for you. These interviews can happen over the telephone, by video call, or in person at a clinic in London or Derby. You will be compensated for your time during these interviews.

Potenzielle Risiken und Vorteile

You may not get any direct medical benefit from joining, although you could earn small cash rewards if you are placed in the reward group. Your feedback will help researchers improve tools that could save lives in the future. There are few physical risks, but answering questions about opioid use and overdose could feel uncomfortable or bring up upsetting memories. Getting alerts on your phone may also feel inconvenient at times. Taking part is entirely voluntary, and you can leave the study whenever you wish without giving a reason and without your normal medical care being affected.

Standorte (1)

  • -
    Ungefähr
    -, England

Häufige Fragen

What is naloxone?

Naloxone is an emergency medicine that temporarily reverses the effects of an opioid overdose, helping a person breathe again while waiting for emergency services.

Do I have to pay anything to use the app?

No, the app is free to use. You will need a smartphone with mobile data, and you can earn small cash payments for taking part.

Will taking part affect my current drug treatment or prescriptions?

No, this study is completely separate from your routine care and will not change your existing prescriptions or treatment plans.

What happens if I forget my naloxone when the app asks?

If you are not carrying your kit, you simply tell the app why. You will still receive a £1 reimbursement for answering honestly.

Where does the study take place?

Participants are recruited through selected harm reduction and drug services in London and Derby. Follow-up interviews can be done over the phone, online, or in person.

Wie Sie mehr erfahren können

Nicola Metrebian

Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.

Interessiert daran, teilzunehmen?

Registrieren Sie Ihr Interesse

Teilen Sie Ihre Details und das Forschungsteam für "App-based financial incentives to encourage naloxone carriag… wird Sie kontaktieren, wenn Sie möglicherweise infrage kommen. Sprechen Sie immer mit Ihrem Hausarzt, bevor Sie zustimmen, teilzunehmen.

Diskussion

Community-Diskussion

Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.